These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20680008)

  • 1. Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity.
    Yang MC; Chang CP; Lei HY
    Lab Invest; 2010 Dec; 90(12):1782-93. PubMed ID: 20680008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoteichoic acid of Bifidobacterium in combination with 5-fluorouracil inhibit tumor growth and relieve the immunosuppression.
    Xie N; Wang Y; Wang Q; Li FR; Guo B
    Bull Cancer; 2012 May; 99(5):E55-63. PubMed ID: 22522606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
    Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J
    Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
    Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
    Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma.
    Du Y; Chen X; Huang ZM; Ye XH; Niu Q
    Asian Pac J Cancer Prev; 2012; 13(8):3815-9. PubMed ID: 23098476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].
    Zhang P; Zhang LN; Zhu FL; Wang Q; Wang XY; Li HY; Liu CM; Gao F; Liu CH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):342-5. PubMed ID: 17892128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
    Sasaki K; Nishina S; Yamauchi A; Fukuda K; Hara Y; Yamamura M; Egashira K; Hino K
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):739-762. PubMed ID: 33191170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
    Jarnicki AG; Lysaght J; Todryk S; Mills KH
    J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X; Du Y; Huang Z
    Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1.
    Han Y; Yang Y; Chen Z; Jiang Z; Gu Y; Liu Y; Xu S; Lin C; Pan Z; Zhou W; Cao X
    J Mol Med (Berl); 2014 May; 92(5):539-50. PubMed ID: 24668348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osthole promotes anti-tumor immune responses in tumor-bearing mice with hepatocellular carcinoma.
    Zhang L; Jiang G; Yao F; Liang G; Wang F; Xu H; Wu Y; Yu X; Liu H
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):301-7. PubMed ID: 25975579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells.
    Wei R; Hu Y; Dong F; Xu X; Hu A; Gao G
    Immunol Cell Biol; 2016 Apr; 94(4):388-99. PubMed ID: 26639061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocarcinoma cell-derived hepatoma-derived growth factor (HDGF) induces regulatory T cells.
    Sun AM; Li CG; Zhang YQ; Lin SM; Niu HR; Shi YS
    Cytokine; 2015 Mar; 72(1):31-5. PubMed ID: 25569374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
    Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
    Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation does not induce the significant increase of CD4(+) CD25(+) Foxp3(+) regulatory T cells compared with surgical resection in Hepal-6 tumor model.
    Gao HJ; Zhang YJ; Liang HH; Li P; Peng ZW; Pang XH; Chen MS
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):333-40. PubMed ID: 23595594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp3+ Regulatory T Cells Inhibit CCl
    Ikeno Y; Ohara D; Takeuchi Y; Watanabe H; Kondoh G; Taura K; Uemoto S; Hirota K
    Front Immunol; 2020; 11():584048. PubMed ID: 33178216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
    Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
    Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increase in peripheral and liver infiltrating regulatory T cells favors development of primary hepatocellular carcinoma].
    Wang SY; Fu JL; Lv JY; Chen LM; Lv S; Wang FS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):668-70. PubMed ID: 21651872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.